Search Results - "Galluccio, N"

KRAS codon 61, 146 and BRAF mutations predict resistance to cetuximab plus irinotecan in KRAS codon 12 and 13 wild-type metastatic colorectal cancer by Loupakis, F, Ruzzo, A, Cremolini, C, Vincenzi, B, Salvatore, L, Santini, D, Masi, G, Stasi, I, Canestrari, E, Rulli, E, Floriani, I, Bencardino, K, Galluccio, N, Catalano, V, Tonini, G, Magnani, M, Fontanini, G, Basolo, F, Falcone, A, Graziano, F

“…Background: KRAS codons 12 and 13 mutations predict resistance to anti-EGFR monoclonal antibodies (moAbs) in metastatic colorectal cancer. Also, BRAF V600E…”
Get full text

Genetic modulation of the Let-7 microRNA binding to KRAS 3′-untranslated region and survival of metastatic colorectal cancer patients treated with salvage cetuximab–irinotecan by Graziano, F, Canestrari, E, Loupakis, F, Ruzzo, A, Galluccio, N, Santini, D, Rocchi, M, Vincenzi, B, Salvatore, L, Cremolini, C, Spoto, C, Catalano, V, D'Emidio, S, Giordani, P, Tonini, G, Falcone, A, Magnani, M

“…There is increasing evidence that the Let-7 microRNA (miRNA) exerts an effect as a tumor suppressor by targeting the KRAS mRNA. The Let-7 complementary site…”
Get full text

High concordance of BRAF status between primary colorectal tumours and related metastatic sites: implications for clinical practice by Santini, D., Spoto, C., Loupakis, F., Vincenzi, B., Silvestris, N., Cremolini, C., Canestrari, E., Graziano, F., Galluccio, N., Salvatore, L., Caraglia, M., Zito, F.A., Colucci, G., Falcone, A., Tonini, G., Ruzzo, A.

Get full text

Role of KRAS let-7 LCS6 SNP in metastatic colorectal cancer patients by Ruzzo, A., Canestrari, E., Galluccio, N., Santini, D., Vincenzi, B., Tonini, G., Magnani, M., Graziano, F.

Get full text

Variations in the interleukin-1 receptor antagonist gene impact on survival of patients with advanced colorectal cancer by Graziano, F, Ruzzo, A, Canestrari, E, Loupakis, F, Santini, D, Rulli, E, Humar, B, Galluccio, N, Bisonni, R, Floriani, I, Maltese, P, Falcone, A, Tonini, G, Catalano, V, Fontana, A, Giustini, L, Masi, G, Vincenzi, B, Alessandroni, P, Magnani, M

“…The interleukin-1 receptor antagonist (IL-1RA) cytokine is thought to counteract tumor angiogenesis/metastasis. Two single nucleotide polymorphisms in the…”
Get full text

Retrospective exploratory analysis of VEGF polymorphisms in the prediction of benefit from first-line FOLFIRI plus bevacizumab in metastatic colorectal cancer by Loupakis, Fotios, Ruzzo, Annamaria, Salvatore, Lisa, Cremolini, Chiara, Masi, Gianluca, Frumento, Paolo, Schirripa, Marta, Catalano, Vincenzo, Galluccio, Nadia, Canestrari, Emanuele, Vincenzi, Bruno, Santini, Daniele, Bencardino, Katia, Ricci, Vincenzo, Manzoni, Mariangela, Danova, Marco, Tonini, Giuseppe, Magnani, Mauro, Falcone, Alfredo, Graziano, Francesco

“…Molecular predictors of bevacizumab efficacy in colorectal cancer have not been identified yet. Specific VEGF polymorphisms may affect gene transcription and…”
Get full text

Let-7a microRNA levels in KRAS -mutated colorectal carcinomas determine survival differences in patients treated with anti-EGFR by Canestrari, E., Ruzzo, A., Vincenzi, B., Galluccio, N., Perrone, G., Andreoni, F., Lorenzini, P., Rulli, E., d'Emidio, S., Catalano, V., Loupakis, F., Bisonni, R., Floriani, I., De Nictolis, M., Santini, D., Salvatore, L., Tonini, G., Falcone, A., Magnani, M., Graziano, F.

“…Abstract only…”
Get full text

C-MET gene copy number variation (CNV) analysis by quantitative PCR (qPCR) assay in Caucasian patients with gastric cancer (GC) by Galluccio, N., Ruzzo, A., Canestrari, E., Lorenzini, P., d'Emidio, S., Sisti, V., Catalano, V., Andreoni, F., Zingaretti, C., De Nictolis, M., Ligorio, C., Cappuzzo, F., Magnani, M., Graziano, F.

“…Abstract only…”
Get full text